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Inflammatory bowel disease (IBD) is a chronic condition of the intestine with unknown etiology
involving multiple immune, genetic and environmental factors. We were interested to examine the effect
of total extract from Zataria multiflora Boiss, a folk medicinal plant on prevention and treatment of
experimental IBD. Z. multiflora was administered (400, 600, 900 p.p.m.) through drinking water to IBD
mice induced by intrarectal administration of acetic acid. Prednisolone was used as the standard drug for
comparison. Biochemical, macroscopic and microscopic examinations of colon were performed.
Biochemical evaluation of inflamed colon was done using assay of myeloperoxidase (MPO) activity and
thiobarbituric acid reactive substances (TBARS) concentration as indicators of free radical activity and
cell lipid peroxidation. The activity of MPO and lipid peroxidation products (TBARS) increased in
acetic acid-treated groups while recovered by pretreatment of animals with Z. multiflora (400–900
p.p.m.) and prednisolone. Z. multiflora (600 and 900 p.p.m.) and prednisolone-treated groups showed
significantly lower score values of macroscopic and microscopic characters when compared with the
acetic acid-treated group. The beneficial effect of Z. multiflora (900 p.p.m.) was comparable with that of
prednisolone. The antioxidant, antimicrobial and anti-inflammatory potentials of Z. multiflora might be
the mechanisms by which this herbal extract protects animals against experimentally induced IBD.
Proper clinical investigation should be carried out to confirm the activity in human.
Keywords: inflammatory bowel disease – antioxidant – cells lipid peroxidation – myeloperoxidase –
rat – Zataria
Introduction
Inflammatory bowel disease (IBD) comprises those conditions
characterized by a tendency for chronic or relapsing immune
activation and inflammation within the gastrointestinal tract.
The intestinal inflammation is histologically characterized
by infiltration of polymorphonuclear leukocytes, monocytes
and macrophages. They are activated by various mediators
including prostaglandins, leukotrienes, platelet-activating fac-
tor and cytokines to synthesize and liberate reactive oxygen
metabolites (1,2).
The balance between the production of free radical and
antioxidant defense in the body has important health implica-
tions: if there are too many free radicals or too few antioxidant
for protection, a condition of oxidative stress develops, which
may cause chronic and pretreatment damage (3). A favorable
correlation between the activity of free radicals (O2,H 2O2,
OH) in the intestine and the clinical disease activity has been
exhibited indicating the significance of these substances in the
inflammatory process (4). Effectiveness of various therapies
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(5–7). The previous studies showed the existence of oxidative
stress in biological fluids such as saliva (8) and plasma (9)
of patients with IBD. One of the markers of oxidative stress
is increased lipid peroxidation of the cells that is determined
by measuring thiobarbituric acid reactive substances (TBARS)
(3). Myeloperoxidase (MPO) is an enzyme found in neutro-
phils and its activity in the colon is linearly related to
infiltration of neutrophils. The assessment of MPO activity
is well established for quantification of intestinal inflammation
(10). In case of inflammatory conditions like IBD, the levels
of neutrophils in inflamed tissues, and consequently
MPO enzyme, increase. Acetic acid-induced colitis is an
easily inducible model of IBD, and the similarity of the
inflammatory mediators profile to IBD mentioned that the
inflammatory phase bears some resemblance to human
intestinal inflammation (11).
Many herbal concoctions are said to be effective in
chronic inflammatory conditions. Labiatae are generally
known for their various effects such as analgesic and anti-
inflammatory activity (12), antioxidant (13), hepatoprotective
(14) and hypoglycemic action (15). Zataria multiflora is a
plant owned by the Labiatae family that is distributed only in
Iran, Pakistan and Afghanistan. It is greatly used for medicinal
and condimental purposes in these countries. This plant with
the vernacular name of Avishan Shirazi in Iran has several
traditional uses such as antiseptic, anesthetic and antispasmo-
dic (16). From these reported activities for this plant and
regarding above-mentioned points about IBD, we hypothe-
sized that Z. multiflora may have an effect on IBD. In this
study, we attempted to demonstrate the status of oxidative
stress by investigating bowel TBARS and MPO activity
accompanied by bowel macroscopic and microscopic findings
in experimental model of IBD (acetic acid-induced colitis)
in mice.
Materials and Methods
Chemicals
2-Thiobarbituric acid (TBA), 1,1,3,3,-tetraethoxypropan,
trichloroacetic acid (TCA), n-butanol, hexadecyl trimethyl
ammonium bromide (HETAB), EDTA, O-dianisidine hydro-
chloride, hydrogen peroxide, acetic acid, prednisolone, phos-
phate buffer, paraffin, hematoxylin and eosin from Merck
Chemical Co. (Germany) were used in this study.
Plant Material
Samples of Z. multiflora were collected from Shiraz, Iran, on
May 22, 2005. The leaves of the plant were dried in shadow
and stored in the Department of Botany of the Research
Institute of Forests and Ranglands (TARI), Tehran. A voucher
specimen (No. 58416) has been deposited at the Herbarium
of TARI.
Preparation of Total Extract
Amount of 86.4 kg of plant powder was wet with a solvent
(methanol) in a closed plastic container; then the wet powder
put in a percolator and was macerated in 10 liters methanol
(100% v/v) for 24 h and, subsequently, the solution was
filtered and concentrated in a percolator by 100 drops per min.
This procedure was repeated twice and three times with 10
liters methanol (100 and 80% v/v), respectively. The extract
was then concentrated under reduced pressure and appropriate
temperature and the solvent was distilled in vacuum, and
finally, 1.5 kg solid solvent was produced.
Animals
NMRI albino mice weighing between 20 and 30 g were used
for the study. Mice were maintained under standard conditions
of temperature (23 ± 1 C), relative humidity (55 ± 10%) and
12 h/12 h light/dark cycle, and fed with a standard pellet diet
with water ad libitum. They were housed in standard
polypropylene cages with wire mesh top. All studies were
carried out using six mice in each group. All ethical con-
siderations using animals were considered carefully and the
experimental protocol was approved by the Ethics Committee
of TUMS.
Induction of Colitis and Treatments
The protocol of the study including doses and duration of
treatment, and groups were all designed according to previous
studies (10,17). The study comprised of six different groups
as follows: normal or untreated mice which did not receive any
treatment; control animals, which received 0.1 ml of 6% acetic
acid solution (once, intrarectally); Z. multiflora-treated ani-
mals, which received 7 days pretreatment with Z. multiflora
(400, 600, 900 p.p.m. in drinking water) and 0.1 ml of 6%
acetic acid solution; prednisolone-treated group, which
received prednisolone (1.14 mg kg
 1, for 3 days) and 0.1 ml
of 6% solution. Acetic acid was administered intrarectally on
8th day. Drug treatment was continued until 10th day.
Prednisolone as standard drug was started on the day of acetic
acid treatment and given orally as suspension containing
0.5% of sodium CMC.
For induction of colitis, overnight fasted mice were
anesthetized using pentobarbital sodium (55 mg kg
 1, i.p.)
and then 0.1 ml of 6% acetic acid solution was instilled into the
rectum of the mouse. Animals were allowed to hang in air by
holding their tails for 1–2 min. This prevented spillage of the
solution from the rectum. After 48 h mice were sacrificed by
cervical dislocation and dissected open to remove colon. Five
centimeters long piece of colon was flushed gently with saline,
cut open and scored for inflammation based on the macro-
scopic features. Tissues were fixed in 10% formalin saline and
examined histopathologically. Biochemical evaluation of
colon inflammation was done using assay of MPO activity
and TBARS concentration.
44 A new natural medicine for IBDAssay of Colon Macroscopic Characters
The colon (5 cm long) was scored for macroscopic features
using scoring pattern (10,17) given in the Table 1.
Assay of Colon Microscopic (Histological) Characters
To process for microscopic studies, 5 mm thick paraffin
sections were stained in hematoxylin and eosin. The stained
sections were examined for any inflammatory changes like
edema, granulated tissues, ulceration or thickening of mucosa,
inflammation, existence of polymorphonuclears and mono-
nuclears, necrosis, disrupted architecture of the crypt, and
narrow lumen. The sections were all recorded by a histo-
pathologist and a sign score between 0 and 3 for each sign and
a total of 24 were used to determine the severity of colon
inflammation (10,17).
Assay of Colon MPO Activity
To measure MPO activity, colonic samples were minced on ice
and homogenized in 10 ml of ice-cold 50 mM potassium
phosphate buffer (pH 6.0), containing 0.5% HETAB and
10 mM EDTA. The homogenates were then sonicated and
centrifuged for 20 min at 12000 g. MPO activity was
measured spectrophotometrically as follows: 0.1 ml of super-
natant was combined with 2.9 ml of 50 mM phosphate buffer
containing 0.167 mg ml
 1 O-dianisidine hydrochloride and
0.0005% H2O2. The change in absorbance was measured
spectrophotometrically (Shimadzu 160A UV-VIS spectro-
photometer) at 460 nm. One unit of MPO activity is defined
as the change in absorbance per minute at room temperature, in
the final reaction. MPO activity (U g
 1) ¼ X/weight of the
piece of tissue taken, where X ¼ 10 · change in absorbance per
minute/volume of supernatant taken in the final reaction (10).
Assay of Colon TBARS Concentration
Malondialdehyde (MDA) is the main end product of the
oxidation of polyunsaturated fatty acids and its concentration
in the medium is an established measure of lipid peroxidation
extent. In this test, the reaction of TBA with lipid peroxide
products makes a complex which is determined spectro-
photometrically and lipid peroxidation in samples are assessed
in terms of TBARS produced. Briefly, the colonic samples
were homogenized in buffered saline (1:5) and then 800 ml
of TCA (28% w/v) was added to 400 ml of this mixture and
centrifuged in 3000 g for 30 min. Then, 600 ml of the
supernatant was added to 150 ml of TBA (1% w/v). Then the
mixture was incubated for 15 min in a boiling water bath and
then 4 ml n-butanol was added, the solution was centrifuged,
cooled and absorption of the supernatant was recorded in 532
nm by UV-160-A Shimadzu double beam spectrophotometer
(Japan). The calibration curve of a 1,1,3,3-tetraethoxypropan
standard solutions was used to determine the concentrations of
TBARS that presented as mmol g
 1 of colon (18).
Statistical analysis
Values are reported as mean ± SEM. Statistical significance
between groups was computed by analysis of variance
(ANOVA) and Tukey multiple comparison post hoc tests.
P-values <0.05 were considered significant.
Results
Significant Macroscopic and Microscopic Changes in
the Colon
Colon macroscopic and microscopic changes in control and
Z. multiflora-treated groups are shown in Tables 2 and 3,
respectively. Intrarectal instillation of acetic acid caused
significant inflammatory reactions as indicated by macroscopic
andmicroscopic changes(Tables2and 3).Z. multiflora-treated
(600 and 900 p.p.m.) and prednisolone-treated groups showed
significantly lower score values of macroscopic and micro-
scopic characters when compared with the control group.
Positive effects of Z. multiflora (900 p.p.m.) in acetic acid-
induced colon macroscopic and microscopic alterations were
comparable with that of prednisolone. Histology photographs of
the colon sections from different treated groups are shown in
Figs 1–6 that match well with macroscopic and microscopic
scores ( Tables 2 and 3).
Lipid Peroxidation Revealed Significant Changes
The changes in the extent of lipid peroxidation in bowel
homogenate of treated animals is shownin Fig. 7. The TBARS
Table 1. Scoring pattern
Percentage area affected Score
00
1–5 1
5–10 2
10–25 3
25–50 4
50–75 5
75–100 6
Table 2. Evaluation based on macroscopic features in acetic acid-induced
colitis
Group Mean of macroscopic
scores ± SEM
Control 4.46 ± 0.57
Prednisolone 1.12 ± 0.14*
Z 400 4.23 ± 0.62
Z 600 2.34 ± 0.49*
Z 900 1.11 ± 0.15*
,†
Observations were recorded by histopathologist and scored as described in
Methods section. Each value represents mean of macroscopic scores ± SEM of
six animals in each group.
*Significant (P < 0.01) decrease in macroscopic score values compared to
control.
†The difference in macroscopic score values of Z. multiflora (Z)-treated and
prednisolone-treated groups in not significant.
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normal group (3.14 versus 5.11 mmol g
 1 colon). The TBARS
level significantly decreased in Z. multiflora-treated (600 and
900 p.p.m.) and prednisolone-treated groups. The mean
percentage of decreases of TBARS in Z. multiflora-treated
(600 and 900 p.p.m.) and prednisolone-treated groups were
22.71, 32.14 and 31.2, respectively.
Colon Myeloperoxidase Activity Changes
The changes in the activity of MPO in bowel homogenates
of treated animals is shown in Fig. 8. The MPO activity of
control group showed significant increase in comparison to
normal group (2.89 versus 4.76 U g
 1 colon). The MPO
activity decreased in Z. multiflora-treated (600 and 900 p.p.m.)
and prednisolone-treated groups compared to control group.
The mean percentages of decreases of MPO activity in
Z. multiflora-treated (600 and 900 p.p.m.) and prednisolone-
treated groups were 24.9, 50, and 48.81, respectively.
Discussion
The results showed that Z. multiflora has a good potential to
suppress colitis in mice as indicated by the macroscopic,
Table 3. Evaluation based on microscopic features in acetic acid-induced
colitis
Group Mean of microscopic
scores ± SEM
Control 23.72 ± 0.69
Prednisolone 5.53 ± 0.40*
Z 400 22.12 ± 0.58
Z 600 12.1 ± 0.70*
Z 900 5.85 ± 0.39*
,†
The sections were all recorded by a histopathologist and a sign score between 0
and 3 for each sign and a total of 24 were used to determine the severity of
colon inflammation. The signs are mentioned in the Methods section (10,17).
Data are mean ± SEM of six observations.
*Significant (P < 0.01) decrease in microscopic score values compared to
control.
†The difference in microscopic score values of Z. multiflora (Z)-treated and
prednisolone-treated groups in not significant.
Figure 1. Light micrograph of bowel tissue from normal or untreated
animals which did not receive any treatment. No major histological changes
are apparent in micrograph. (H & E, ·40 and ·100).
Figure 2. Light micrographs of bowel tissues from control mice received
0.1 ml of 6% acetic acid solution (once, intrarectally). Major histological
changes are apparent in micrograph. Ed, edema; TM, thickened mucosa; GT,
granulated tissue; In, inflammation; NL, narrowed lumen; Ne, necrosis; DAC,
disrupted architecture of the crypt; PMN, polymorphonuclears; MN, mono-
nuclear; FUM, focal ulceration of mucosa (H & E, ·40 and ·100).
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well indicated that administration of Z. multiflora reduces
MPO activity and TBARS concentrations, both of which are
established indicators of oxidative stress and markers of colitis
(8,11,19). Interestingly, Z. multiflora specially at dose of
900 p.p.m. was comparable with prednisolone which showed
significant protection against acetic acid-induced colitis
proved by biochemical, macroscopic and microscopic examina-
tions. Acetic acid-induced colitis model in mice is similar
to human ulcerative colitis in terms of histological features. It
affects the distal colon portion and induces non-transmural
inflammation, massive necrosis of mucosal and submucosal
layers,mucosal edema,neutrophilinfiltrationofthe mucosaand
submucosalulceration.Theprotonatedformoftheacidliberates
protons within the intracellular space and causes a massive
intracellular acidification resulting in massive epithelial
damage. Inflammation is the pathogenesis of IBD and several
pathways are associated with inflammatory response in IBD.
The inflammatory response initiated by acetic acid includes
activation of cyclooxygenase and lipooxygenase pathways
(20,22). Prednisolone as an anti-inflammatory agent decreases
the recruitment of macrophages in the affected area and
suppresses the synthesis of many inflammatory mediators, e.g.
production of IL-1 from monocytes, production of IL-2 and
tumor necrosis factor from lymphocytes. Prednisolone also
Figure 3. Light micrographs of bowel tissues from prednisolone-treated
group, which received prednisolone (1.14 mg kg
 1 for 3 days) and acetic acid
(0.1 ml, 6% solution, once, intrarectally). Minor histological changes are
apparent (H & E, ·40 and ·100).
Figure 4. Light micrograph of bowel tissue from Z. multiflora-treated animals,
which received 7 days pretreatment with extract (400 p.p.m. in drinking water)
and 0.1 mlof6%aceticacidsolution.Majorhistologicalchanges are apparentin
micrograph. Ed, edema; GT, granulated tissue; In, inflammation; Ne, necrosis;
DAC, disrupted architecture of the crypt; PMN, polymorphonuclears; MN,
mononuclear; TM, thickened mucosa (H & E, ·40 and ·100).
Figure 5. Light micrograph of bowel tissue from Z. multiflora-treated
animals, which received 7 days pretreatment with extract (600 p.p.m. in
drinking water) and 0.1 ml of 6% acetic acid solution. Some histological
changes are apparent. Ed, edema; In, inflammation; DAC, disrupted
architecture of the crypt; NL, narrowed lumen; FUM, focal ulceration of
mucosa; GT, granulated tissue (H & E, ·40 and ·100).
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availability of prostaglandins and leukotrienes (23). Therefore,
the first concept that may come to mind is that Z. multiflora
possesses inhibitory effects on the synthesis or release of these
inflammatory mediators. Supporting this idea, antinociceptive
and anti-inflammatoty effects of the aqueous infusion,
ethanolic maceration extract (24,25), the hydroalcoholic
extract and the essential oil (26) of the aerial parts of
Z. multiflora have been shown and are possibly due to the
inhibition of cyclooxygenase enzymes (24). The composition
of the essential oil of Z. multiflora was studied by GLC,
column chromatography (CC), NMR and GLC/MS (27–30).
Zatarinal, b-sitosterol, stigmasterol, oleanolic acid, betulic
acid, hexadecanoic, luteolin, a-tocophorolquinone and
rosmarinic acid (RA) were reported as the composition of
Z. multiflora essential oil. On the other hand, phytochemical
screening of ethanolic extract of the plant supported the
presence of flavonoids in Z. multiflora (31,32), mainly
carvacrol, p-cymene, thymol, linalool and g-terpinene (29).
The luteolin, one of the compositions of Z. multiflora has
shown inhibitory effects on TNF-a-induced IL-8 production in
the intestinal epithelial cells. Interleukin IL-8 plays a central
role in the initiation and maintenance of inflammatory
responses in the IBD (33).
The RA another component of Z. multiflora essential oil has
been reported to have antibacterial, antiviral, antioxidant and
anti-inflammatory potentials (34–36). RA inhibits the adhe-
sion molecule ICAM-1, which is primarily involved
in interactions with b2 integrins during inflammatory
responses, and inhibits the synthesis of eicosanoids, and
oxidative DNA injury (36,37). Oxidative stress is believed to
play a key role in the pathogenesis of IBD-related intestinal
damage (8,9,38–42). As a matter of fact, intestinal mucosal
damage in the IBD, including Crohn’s disease and ulcerative
colitis, is related to both increased free radical production and
to a low concentration of endogenous antioxidant defense
(43,44). Supporting this idea, the activity of MPO, which is a
major enzyme in the formation of reactive oxygen species
leading to tissue damage increased in this colitis model.
Together with the membranous NADPH oxidase, MPO is
involved in the formation of reactive oxygen species and
oxidation of biological material. It produces not only oxidative
equivalents, but contributes also to the regulation in general
Figure 6. Light micrograph of bowel tissue from Z. multiflora-treated
animals, which received 7 days pretreatment with extract (900 p.p.m. in
drinking water) and 0.1 ml of 6% acetic acid solution. Ed, edema; NL,
narrowed lumen; DAC, disrupted architecture of the crypt. Minor histological
changes are apparent (H & E, ·40 and ·100).
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Figure 7. Effects of Z. multiflora (Z) and prednisolone on lipid peroxidation
in acetic acid-induced colitis. Each value represents mean ± SEM percentage
of reduction of acetic acid-induced TBARS elevation by treated compounds.
The mean ± SEM of TBARS level in normal and control groups were 3.14 ±
0.31 and 5.11 ± 0.50 (mmol g
 1 colon), respectively.
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Figure 8. Effects of Z. multiflora (Z) and prednisolone on MPO activity in
acetic acid-induced colitis. Each value represents mean ± SEM percentage of
reduction of acetic acid-induced MPO elevation by treated compounds. The
mean ± SEM of MPO activity in normal and control groups were 2.89 ± 0.17
and 4.76 ± 0.15 (U g
 1 colon), respectively.
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as a marker of lipid peroxidation observed in association with
higher MPO activity in this experimental colitis model again
confirms the role of free radicals in IBD.
Flavonoids as the main constituent of Z. multiflora extract
are a class of plant phenolics with significant antioxidant and
chelating properties. Their positive effects come from their
ability to inhibit lipid peroxidation, chelate redox-active
metals and attenuating other procedure involving reactive
oxygen species. From this point of view, there is a great
interest in interactions betweenpolyphenolic substance and the
intestinal mucosa, including their possible role as modulators
of proliferation and apoptosis in the rapidly proliferating cells
of the gastrointestinal epithelia (45,46). Recent studies have
shown that flavonoids exert a beneficial effect in experimental
colon inflammation (47,48). In addition, the anti-inflammatory
effects of flavonoids seem to be related to a decrease of
neutrophils infiltration, absence of upregulation of IL-1b and
decrease of prostaglandin production in colon mucosa (49). In
supporting this idea, there is evidence that flavonoids have
anti-phosphodiesterase activity and thus could elevate intra-
cellular levels of cyclic nucleotides (50). Recent studies well
indicate that both cAMP and cGMP can diminish oxidative
stress in many biological systems and diseases (51–56).
Therefore, the beneficial effects of Z. multiflora in IBD mostly
back to its strong antioxidant potential.
On the other hand, GC-MS in the absolute of fresh plant
showed that thymol is the major constituent while carvacrol
is the major constituent in the absolute of dried plant (57).
The Z. multiflora oil exhibited strong antimicrobial activity
against Escherichia coli, Staphylococcus aureus and
Salmonella typhimurium (58–60). In addition, both thymol
and carvacrol in Z. multiflora essential oil exerted antibacterial
and antifungal effects (61). Thus, antimicrobial activity of
Z. multiflora can be another mechanism of action for its
beneficial effects in IBD.
Conclusion
Taking collectively, the data provide very good evidence
on benefit of Z. multiflora in experimental model of IBD.
This effect supports the antioxidant, antimicrobial and anti-
inflammatory potentials of Z. multiflora. Regarding the
resemblance of acetic acid-induced colitis to human UC (62),
it can be concluded that Z. multiflora extract may be useful
in treating UC in humans. Proper clinical investigations
should also be carried out to confirm the same activity in
human disease. It should not be forgotten that there are a lot of
herbal formulas in the Asia and Middle East regions that are
used traditionally. However, little effort has been made so far
to scientifically clarify the nature of such effects. Scientists
from these regions of the world are responsible for confirming
the pharmacological effects of these herbals by suitable animal
tests. Many of them are capable entering clinical trials and
deserve to be used as a drug in humans with minor adverse
effects in comparison to synthetic compounds (63,64).
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